Abbott alinity m reagents and consumables
Ended Awarded Last action
- Contract number
- 36C26124F0252
- Awardee
-
Abbott Molecular Inc. UEI NK5QDVJBHMN7 Part of Abbott Laboratories
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $3,687,026
Award facts
- Contract value 44% obligated
-
- $3,687,025.74 Current, with exercised options
- $8,383,077.64 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rosemont, IL 60018, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$44,371 | |
| Supplemental Agreement for work within scope | -$379,455 | |
| Exercise an Option | $1,826,981 | |
| Funding Only Action | -$155,882 | |
| Exercise an Option | $1,826,981 | |
| Other Administrative Action | $0 | |
| Original award | $612,771 |
About this award
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, received a delivery order valued at $8.38 million from Veterans Integrated Service Network 21 for Alinity M reagents and consumables, effective April 1, 2024, through March 31, 2029. This award is issued under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule as a firm fixed-price contract with no small business set-aside designation. The contract supports the Veterans Health Administration's molecular diagnostic testing infrastructure by providing reagents and consumables for Abbott's Alinity M platform, which performs infectious disease screening including COVID-19, HIV, hepatitis C, and human papillomavirus testing. Funding is provided by the Department of Veterans Affairs through VISN 21, which serves veterans across the Pacific Northwest region.
This delivery order represents a continuation of Abbott Molecular's established relationship with the VA across multiple Veterans Integrated Service Networks, where the company maintains numerous blanket purchase agreements and task order vehicles exceeding $40 million in aggregate value. The award reflects Abbott Molecular's role as a critical supplier of in vitro diagnostic reagents and molecular testing platforms to federal healthcare agencies. As a large, established medical technology corporation with no small business designation, Abbott Molecular competes under unrestricted GSA schedules and has demonstrated sustained federal demand for its diagnostic reagent supply agreements across VA facilities nationwide.
Quick answers
Who was awarded contract 36C26124F0252?
36C26124F0252 was awarded to Abbott Molecular Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on April 1, 2024.
How much is contract 36C26124F0252 worth?
The government has obligated $3,687,026 on 36C26124F0252. Its potential value, with all options, is $8,383,078.
Is contract 36C26124F0252 an order under another contract?
Yes. 36C26124F0252 is a delivery order under V797P7323A, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract 36C26124F0252 competed?
The extent of competition for 36C26124F0252 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award